Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Somatrogon is a long-acting recombinant human growth hormone used as the long-term treatment of pediatric patients who have growth failure due to growth hormone deficiency. Growth hormone is a peptide hormone secreted by the pituitary gland that plays a crucial role in promoting longitudinal growth during childhood and adolescence and regulating metabolic function in adulthood.
- Mechanism
- Curator reviewed · 3 references
Growth hormone is a key hormone that promotes body growth and regulates carbohydrate, protein and lipid metabolism. Somatrogon is a hormone replacement therapy that aims to restore deficient levels of growth hormone (GH). Like endogenous growth hormone, somatrogon binds to the GH receptor, which leads to the binding of JAK2 to GH receptor and activation of JAK2. Activation of JAK2 and phosphorylation of both JAK2 and GHR initiates the recruits various signalling proteins and facilitates multiple signalling pathways responsible for growth and metabolism. One of the activated signalling pathways is the STAT5b signalling pathway, which is critical for the effect of GH on body height.
- Primary indication
- Somatrogon is indicated for the long-term treatment of pediatric patients who have growth failure due to an inadequate secretion of endogenous growth hormone (growth hormone deficiency).Curator reviewed · 2 structured indications
- Formula / weight
- C1359H2125N361O420S7 · 30465.1 Da (Aglycosylated)
- First approval
- Canada, 2021 · United States, 2023 · European Union, 2022
- Also known as
- 118-145-GONADOTROPIN, CHORIONIC (HUMAN .BETA.-SUBUNIT) FUSION PROTEIN WITH SOMATOTROPIN (HUMAN) FUSION PROTEIN WITH 118-145-CHORIONIC GONADOTROPIN (HUMAN .BETA.-SUBUNIT) FUSION PROTEIN WITH 118-145-CHORIONIC GONADOTROPIN (HUMAN .BETA.-SUBUNIT) · CTP-SOMATROPIN FUSION PROTEIN · FUSION PROTEIN OF HUMAN CHORIOGONADOTROPIN SUBUNIT .BETA. (CG- .BETA.)-(118-145)-PEPTIDE (1-28) WITH HUMAN SOMATOTROPIN (GROWTH HORMONE, GH) (29-219) AND TWO TANDEM COPIES OF HUMAN CHORIOGONADOTROPIN SUBUNIT .BETA. (CG-.BETA.)-(118-145)- PEPTIDE (220-247 · HUMAN GROWTH HORMONE-CARBOXY-TERMINAL PEPTIDE (CTP) OF THE BETA CHAIN OF HUMAN CHORIONIC GONADOTROPIN FUSION PROTEIN · MOD-423 hGH analogue
- Code names
- MOD-4023
- Brand names
- Ngenla
Resolves to
What you can answer from here — as of March 06, 2025
Which drugs share a target with Somatrogon, and which of those have an active Phase 3 trial?